NCT06107348View on ClinicalTrials.gov

COVID-19 Post-Vaccination Observation

Active, not recruitingOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

January 4, 2023

Study Completion Date

December 24, 2023

Conditions
Immune System DiseasesCOVID-19 Vaccine Adverse ReactionImmune System Disorder
Trial Locations (1)

402762

Residential Address, Chongqing

All Listed Sponsors
lead

Yang I. Pachankis, PhD

INDIV